<?xml version='1.0' encoding='utf-8'?>
<document id="28682150"><sentence text="Drug-drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia."><entity charOffset="44-54" id="DDI-PubMed.28682150.s1.e0" text="pipamperon" /><entity charOffset="59-70" id="DDI-PubMed.28682150.s1.e1" text="ondansetron" /><pair ddi="false" e1="DDI-PubMed.28682150.s1.e0" e2="DDI-PubMed.28682150.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28682150.s1.e0" e2="DDI-PubMed.28682150.s1.e1" /></sentence><sentence text="Pipamperon is a potent neuroleptic drug with many side effects, including prolongation of the QT interval" /><sentence text=" We report a case of a child treated for leukemia in which prolongation of the QT interval was observed" /><sentence text=" Physicians and pharmacists should be cautious for drug-drug interactions when pipamperon is prescribed, especially in combination with other QT-prolongating agents" /><sentence text=" Alternative strategies should be used whenever possible" /><sentence text="" /></document>